Drug makers' suppliers may have to merge
To cut costs, many firms opt to deal with fewer vendors
When Charles River Laboratories Inc. chief executive James C. Foster looks across Massachusetts, he sees a string of major companies supplying drug firms with services and equipment. (Full article: 677 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
